Invention Grant
- Patent Title: Administration regimen of compositions of T4 thyroid hormone with high oral absorption
-
Application No.: US16421373Application Date: 2019-05-23
-
Publication No.: US11241382B2Publication Date: 2022-02-08
- Inventor: Tiziano Fossati , Giuseppe Mautone , Claudia Scarsi
- Applicant: ALTERGON SA
- Applicant Address: CH Lugano
- Assignee: ALTERGON SA
- Current Assignee: ALTERGON SA
- Current Assignee Address: CH Lugano
- Agency: Fenwick & West LLP
- Priority: IT102019000003013 20190301
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/198 ; A61P5/14
Abstract:
New administration regimens of the T4 thyroid hormone are described, characterized by the use of alcohol-free, water-glycerol solutions of said hormone, administered at short temporal distance, i.e. within less than 30 minutes, typically between 15 and less than 30 minutes, from the closest consumed meal.
Public/Granted literature
- US20200276112A1 ADMINISTRATION REGIMEN OF COMPOSITIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION Public/Granted day:2020-09-03
Information query
